[HTML][HTML] Nootropic and anti-Alzheimer's actions of medicinal plants: molecular insight into therapeutic potential to alleviate Alzheimer's neuropathology

MS Uddin, A Al Mamun, MT Kabir, M Jakaria… - Molecular …, 2019 - Springer
Medicinal plants are the backbone of modern medicine. In recent times, there is a great urge
to discover nootropic medicinal plants to reverse cognitive dysfunction owing to their less …

Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration

HH Andersen, KB Johnsen, T Moos - Cellular and molecular life sciences, 2014 - Springer
Neurodegenerative disorders are characterized by the presence of inflammation in areas
with neuronal cell death and a regional increase in iron that exceeds what occurs during …

BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment

D Gezen-Ak, E Dursun, H Hanağası… - Journal of …, 2013 - content.iospress.com
Identifying early-detection biomarkers have become an increasingly important approach in
the treatment and prevention of Alzheimer's disease (AD). In this study, we investigated the …

Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice

J Zhang, J Guo, X Zhao, Z Chen, G Wang, A Liu… - Behavioural brain …, 2013 - Elsevier
Memory deficit is a marker of Alzheimer's disease (AD) that has been highly associated with
the dysfunction of cyclic GMP (cGMP) signaling and an ongoing inflammatory process …

Why vitamin D in Alzheimer's disease? The hypothesis

D Gezen-Ak, S Yılmazer… - Journal of Alzheimer's …, 2014 - content.iospress.com
Scientists have worked for over a century to uncover the basis of Alzheimer's disease (AD)
with the ultimate goal of discovering a treatment. However, none of the approaches utilized …

Preclinical evaluation of 18F-JNJ64349311, a novel PET tracer for tau imaging

L Declercq, F Rombouts, M Koole… - Journal of nuclear …, 2017 - Soc Nuclear Med
In this study, we have synthesized and evaluated 18F-JNJ64349311, a tracer with high
affinity for aggregated tau (inhibition constant value, 8 nM) and high (≥ 500×) in vitro …

Pharmacogenomics of Alzheimer's disease: Novel therapeutic strategies for drug development

R Cacabelos, P Cacabelos, C Torrellas… - … in Drug Discovery and …, 2014 - Springer
Alzheimer's disease (AD) is a major problem of health and disability, with a relevant
economic impact on our society. Despite important advances in pathogenesis, diagnosis …

[PDF][PDF] Propofol: an anesthetic possessing neuroprotective effects.

W Fan, X Zhu, L Wu, Z Wu, D Li… - European Review for …, 2015 - researchgate.net
Propofol is a short-acting intra-venous anaesthetic agent and widely used not only in
operating rooms but also in the intensive care unit (ICU). Apart from its multiple anaesthetic …

[HTML][HTML] Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway

Z Zeng, J Xu, W Zheng - Redox biology, 2017 - Elsevier
Accumulating evidence displays that an abnormal deposition of amyloid beta-peptide (Aβ) is
the primary cause of the pathogenesis of Alzheimer's disease (AD). And therefore the …

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

K Blennow, H Hampel, H Zetterberg - Neuropsychopharmacology, 2014 - nature.com
Drug candidates directed against amyloid-β (Aβ) are mainstream in Alzheimer's disease
(AD) drug development. Active and passive Aβ immunotherapy is the principle that has …